【Purpose】The usefulness of atropine sulfate eye drops (atropine) for refraction in treating strabismus and amblyopia is well known. However, the use of atropine eye drops requires extra time and has potential side effects. In this study, the use of atropine for refraction examination in the Amblyopia and Strabismus Outpatient Department of the Otsuka Eye Hospital was investigated. 【Subjects and Methods】The subjects were 83 patients who visited the department between April 2011 and March 2015 and received atropine instillation for refraction examination. Subjectsʼ age distribution, type of visual abnormality, the incidence of side effects, refractions using cyclopentolate hydrochloride (cyclopentolate) and atropine, and comparison between the refraction results obtained after the first and second (one year later) atropine instillations were all investigated. 【Results】The ages of the subjects ranged from 1 to 7 years, with an average of 3.8 ± 1.4 years. Hypermetropia was observed in the majority of subjects. Of 83 subjects, 3 (3.6%) had side effects that were relieved immediately without interrupting the atropine instillation. In 14 eyes of 7 subjects, both atropine and cyclopentolate were used in the refraction tests and compared. The refraction using atropine was higher than the refraction using cyclopentolate by an average of +0.16 ± 0.33 D. Although it was not included in the current results, some subjects tested with cyclopentolate were found to have hypermetropia one year later using atropine instillation. Vision was improved by eye glasses in some of the subjects. 【Conclusion】The use of atropine in refraction examination may require extra time, and cyclopentolate could be used instead in follow-up. However, atropine appeared to have mild side effects, and its usefulness was again recognized in this study. It appears that the use of atropine could be further promoted.
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